The Price of Ozempic Is a Meaningless Phrase
2 Articles
2 Articles
After the success of weight loss drugs such as Ozempic or Wegovy, a financial time bomb is hidden whose expansive wave threatens to destabilize both public budgets and private insurance. A new study led by Northwestern University (United States) warns that the total cost of these treatments — the real bill that adds up to what the patient, insurers and the state pay — has increased untenablely in just a five-year period.
The price of Ozempic is a meaningless phrase
By JOHN SAMARAS Ask what Ozempic costs. The honest answer runs from $25 a month to $1,100 a month, and every number in that range is real, published, and defensible. A phrase that covers a forty-four-fold spread is not a price. It is a fog, and patients make four-figure annual decisions inside it. I run GLP Chart, an independent GLP-1 price index. The index shows that “the price of Ozempic” fails as a concept for three stacked reasons. The molec…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
